A panel of experts discuss recent updates on the use of MRI/ultrasound fusion-guided biopsy in patients with prostate cancer.
EP. 1: The Role of Imaging in Diagnosing and Staging Prostate Cancer
A panel of experts on prostate cancer introduce themselves and begin the discussion with clinical insights on diagnostic practices and the importance of biopsy and imaging in guiding treatment decisions.
EP. 2: Advances in Prostate Biopsy
Focusing on prostate cancer diagnosis, the panel discusses transrectal and transperineal biopsies and limitations associated with them.
EP. 3: Benefits of Incorporating Fusion-Guided Biopsy into Practice
Firas F. Abdollah, MD, provides insights on how MRI- or fusion-guided technologies are used with transrectal and transperineal biopsy procedures and how they improve traditional biopsy procedures.
EP. 4: A Review of the Data for Fusion-Based Biopsy Procedures
The panel discusses data on the accuracy of MRI-targeted or fusion-based biopsy procedures compared with systemic biopsy or MRI alone.
EP. 5: Understanding Differences in Fusion-Guided Biopsy Technologies
Experts on prostate cancer focus on the differences between fusion-guided technologies, highlighting cognitive-based and software-based fusions.
EP. 6: The Role for Systematic Biopsy Plus MRI-Targeted Procedures
Focusing on the role of systematic biopsy, the panel provides clinical insights on biopsy practice patterns after encountering suspicious-looking areas on MRI.
EP. 7: Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer
A panel of experts on prostate cancer discuss the role for fusion-guided biopsies in active surveillance for patients with prostate cancer.
EP. 8: Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.
EP. 9: Incorporating Fusion-Guided Biopsy to Practice
Prostate cancer specialists provide insights on the integration of fusion biopsy into clinical practice and how it has impacted treatment paradigms.
EP. 10: Future Directions for Imaging and Biopsy in Prostate Cancer
The panel offers key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer.
EP. 11: The Impact of MRI-Guided Biopsy in Diagnosis and Treatment Decisions
Kyrollis Attalla, MD, shares his approach to imaging and biopsy in the diagnosis of prostate cancer and discusses the benefit of a good biopsy followed by appropriate imaging at initial diagnosis.
EP. 12: Overcoming Limitations of Traditional Biopsies with MRI-Guided Biopsies
A urologic oncologist discusses how MRI- or fusion-guided biopsies have helped overcome the limitations of traditional prostate biopsies.
EP. 13: An Overview of Fusion-Guided Systems
EP. 14: Fusion-Based Biopsies in Active Surveillance
Kyrollis Attalla, MD, describes the role of fusion-based biopsies in active surveillance for patients with prostate cancer and how this technology has improved monitoring and treatment strategies.
EP. 15: Expert Insights on MRI-US Fusion-Guided Biopsy
EP. 16: The Impact of Fusion-Guided Biopsy on Focal Therapy in Prostate Cancer
An expert on prostate cancer discusses how fusion-guided biopsy can help determine patient eligibility for focal therapy.
EP. 17: Looking Ahead: Image-Guided Diagnostic Tools
Kyrollis Attalla, MD, remarks on emerging imaging technologies for patients with prostate cancer and the growing pool of candidates for focal therapy.
FDA authorizes Expanded Access Program of Anktiva for lymphopenia
Prostate cancer awareness in 2025: A human imperative in the wake of President Biden’s diagnosis
Pivotal trial of histotripsy system for kidney tumors reaches enrollment goal
Study finds racial/ethnic disparities in use of PSMA-PET in prostate cancer